NeoCodex SL

NeoCodex is dedicated to securing its research through the development of three specialized technological platforms: a human sample repository, advanced sequencing infrastructure, and an innovative bioinformatics technology platform. These platforms enable NeoCodex to conduct independent research and have led to the development of a new tool called Hypothesis Free Clinical Cloning (HFCC). HFCC is designed for large-scale data analysis and uses n-genic models to identify associations between DNA variations and the development of complex diseases, as well as different responses to medication. This tool has significant potential for identifying new therapeutic targets that may be overlooked by traditional methods.